Benchmark notes that shares of Dave (DAVE) came under pressure during Tuesday’s trading session after the Federal Trade Commission announced it had referred the lawsuit it filed against the company on November 5 to the Department of Justice, which in turn amended and refiled the complaint. While the news of the FTC’s referral of its lawsuit to the DOJ caused a downdraft in share price, the firm sees “a few reasons” why investors should view the pullback as “an opportunity to add to or initiate positions,” the analyst says. “Heading this list” is the fact that the Biden Administration DOJ staff who filed the amended complaint against Dave is poised to be replaced in a matter of weeks by new Trump Administration appointees, who are likely to interpret the issues at hand in the case through “a much more business-friendly lens,” contends the analyst, who reiterates a Buy rating and $119 price target on Dave shares.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVE:
- CompoSecure to spin off Resolute, EHang raises Q4 revenue view; Morning Buzz
- Morning Movers: EHang jumps following guidance raise
- Fintech App Dave Dives Lower on DOJ Complaint
- Dave says amended FTC complaint is ‘continued example of government overreach’
- Dave Faces FTC Complaint, Revises ExtraCash Fees